<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-140255" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Retinal Pattern Dystrophy</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Ahmed</surname>
            <given-names>Harris</given-names>
          </name>
          <aff>University of Southern California</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Sierpina</surname>
            <given-names>David I.</given-names>
          </name>
          <aff>Loma Linda University Eye Institute</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Khazaeni</surname>
            <given-names>Leila</given-names>
          </name>
          <aff>Loma Linda University</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Harris Ahmed declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>David Sierpina declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Leila Khazaeni declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>16</day>
          <month>7</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-140255.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Retinal pattern dystrophies represent several diseases that involve a variety of patterns of pigment deposition in the retinal pigment epithelium (RPE) of the macula. Given the RPE's critical role in waste removal, many pattern dystrophies feature waste accumulation primarily of lipofuscin. Typically, these dystrophies are associated with a good visual prognosis; however, there remains a risk for progressive central vision loss. Pattern dystrophies are usually inherited, often presenting in the fourth and fifth decades of life. The disease may present diagnostic confusion when presenting in the elderly and is often confused for age-related macular degeneration. To establish a clear diagnosis of retinal pattern dystrophy, it is important to appropriately work up and follow this condition. This activity reviews the evaluation, diagnosis, and management of retinal pattern dystrophies and highlights the role of the interprofessional team in following patients with this condition.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Describe the various disease entities that make up retinal pattern dystrophies.</p></list-item><list-item><p>Outline the typical exam findings of a patient with retinal pattern dystrophy.</p></list-item><list-item><p>Identify the diagnostic modalities necessary to diagnose retinal pattern dystrophy.</p></list-item><list-item><p>Summarize treatment and common complications of retinal pattern dystrophies.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=140255&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=140255">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-140255.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Retinal pattern dystrophies are a slowly progressive heterogeneous group of primarily autosomal dominantly inherited macular diseases whose unifying element involves the deposition of pigment in the retinal pigment epithelium (RPE) of the macula.<xref ref-type="bibr" rid="article-140255.r1">[1]</xref>&#x000a0;</p>
        <p>Although findings are classically and most often centered in the macula, pigment deposition may also occur in the periphery.<xref ref-type="bibr" rid="article-140255.r1">[1]</xref>&#x000a0;Depending on the distribution pattern, these pattern dystrophies can be separated into major categories or types. These include reticular dystrophy, fundus pulverulentus, butterfly-shaped pigment dystrophy, adult-onset foveomacular vitelliform dystrophy, and multifocal pattern dystrophy simulating Stargardt disease. Interestingly, within a patient, a given pattern may transform into another pattern. Each eye may have distinct patterns, and the same familial mutation can correspond to different phenotypic patterns.<xref ref-type="bibr" rid="article-140255.r2">[2]</xref><xref ref-type="bibr" rid="article-140255.r3">[3]</xref><xref ref-type="bibr" rid="article-140255.r4">[4]</xref><xref ref-type="bibr" rid="article-140255.r5">[5]</xref>&#x000a0;</p>
        <p>Visual prognosis is typically good in these patients, but due to the location of the pigment deposition in the macula and its slowly progressive nature, there is always the possibility of central vision loss and secondary complications such as choroidal neovascularization and macular holes.<xref ref-type="bibr" rid="article-140255.r4">[4]</xref><xref ref-type="bibr" rid="article-140255.r6">[6]</xref></p>
        <p>Patients typically remain asymptomatic until the fourth to fifth decade of life, when they may start to notice changes in central vision. The appearance of pattern dystrophies may lead to misdiagnosis as age-related macular degeneration (AMD), especially given that later stages of pattern dystrophies may resemble AMD and pigment deposits can resemble drusen.<xref ref-type="bibr" rid="article-140255.r6">[6]</xref>&#x000a0;Distinguishing pattern dystrophies from AMD requires further workup and follow-up.<xref ref-type="bibr" rid="article-140255.r4">[4]</xref></p>
      </sec>
      <sec id="article-140255.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>Pattern dystrophies are attributed to mutations in the human retinal degeneration slow (RDS) and peripherin gene on chromosome 6 at position 21.1.<xref ref-type="bibr" rid="article-140255.r7">[7]</xref>&#x000a0;There are various mutations, such as multiple missense mutations including Arg172Trp, Lys197Glu, Tryp246Arg, Cys213Ttr, Gly167Asp, Glu208Asp, Trp246Arg, and Cys250Phe, and nonsense mutations such as Tyr285ter and Gln239ter.<xref ref-type="bibr" rid="article-140255.r6">[6]</xref><xref ref-type="bibr" rid="article-140255.r8">[8]</xref><xref ref-type="bibr" rid="article-140255.r9">[9]</xref><xref ref-type="bibr" rid="article-140255.r10">[10]</xref>&#x000a0;</p>
        <p>The RDS/Peripherin gene is critical for developing a protein, peripherin-2, a cell surface glycoprotein that may be involved in developing and stabilizing photoreceptor outer segment discs.<xref ref-type="bibr" rid="article-140255.r11">[11]</xref><xref ref-type="bibr" rid="article-140255.r12">[12]</xref>&#x000a0;</p>
        <p>It is theorized that a mutation in the function of this protein may lead to pattern dystrophy disease by compromising the integrity of photoreceptor membranes.<xref ref-type="bibr" rid="article-140255.r7">[7]</xref><xref ref-type="bibr" rid="article-140255.r11">[11]</xref></p>
      </sec>
      <sec id="article-140255.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>Due to the rarity of the disease, epidemiological data is limited to regional analysis. One study found the prevalence of pattern dystrophies in northern France to be 33,800 in total or a 1&#x000a0;per1490 ratio, and over 300,000 in greater Europe.<xref ref-type="bibr" rid="article-140255.r13">[13]</xref>&#x000a0;Another study found the prevalence of adult-onset vitelliform macular dystrophy ranges from 1 in 7400 to 1 in 8200.<xref ref-type="bibr" rid="article-140255.r14">[14]</xref></p>
      </sec>
      <sec id="article-140255.s5" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>While pattern dystrophies are found on routine screenings for most patients, some patients may present with a decrease in vision and metamorphopsia.<xref ref-type="bibr" rid="article-140255.r15">[15]</xref>&#x000a0;On rare&#x000a0;occasions, patients may report a history of significant vision loss secondary to complications from pattern dystrophies such as choroidal neovascularization. On physical exam, the fundus exam will reveal a characteristic pattern of pigment deposition in the RPE.</p>
        <p>The nature and description of the pattern will define the type of pattern dystrophy the patient has. Imaging modalities such as fluorescein angiography (FA), fundus autofluorescence (FAF), EOG, and ERG may provide additional information to stage and define the pattern dystrophy; however, diagnosing pattern dystrophy is a clinical diagnosis.&#x000a0;While all pattern dystrophies are associated with pseudoxanthoma elasticum, fundus pulverulentus has the&#x000a0;strongest association.<xref ref-type="bibr" rid="article-140255.r16">[16]</xref>&#x000a0;</p>
        <p>Additionally, maternally inherited diabetes and deafness have shown to have a significant correlation with pattern dystrophies, with some estimates placing it over 80%.<xref ref-type="bibr" rid="article-140255.r17">[17]</xref></p>
      </sec>
      <sec id="article-140255.s6" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>Butterfly-shaped pattern dystrophy is named after the characteristic bilateral pigmented deposits seen in a butterfly pattern at the RPE. Typically, there is a central area of RPE atrophy, outside of which there is RPE distention from lipofuscin.<xref ref-type="bibr" rid="article-140255.r7">[7]</xref>&#x000a0;The color of the pigment ranges from black to yellow or white. On FA, these pigmented areas block fluorescence, and&#x000a0;the central lesion is easily visible, distinguishing this dystrophy from others.<xref ref-type="bibr" rid="article-140255.r7">[7]</xref>&#x000a0;</p>
        <p>FAF will reveal areas of both increased and decreased autofluorescence corresponding to lipofuscin changes. ERG and EOG will reveal mild changes; however, patients maintain normal vision. Patients are able to maintain good vision in the first two to three decades of life; however, fifth decade and beyond, vision changes may occur with corresponding atrophic depigmented lesions seen on FAF and FA.<xref ref-type="bibr" rid="article-140255.r18">[18]</xref></p>
        <p>Reticular dystrophy features a network of pigmented lines and knots&#x000a0;in a fish net-like appearance in the RPE. Lesions are up to five disc diameters from the macula and typically fade away with age. Some of the lesions that fade away leave atrophic changes that appear irregular with white dots in the RPE.<xref ref-type="bibr" rid="article-140255.r18">[18]</xref>&#x000a0;FA will reveal hypoflourescent segments surrounding areas of hyperfluorescence with normal choroidal vasculature.<xref ref-type="bibr" rid="article-140255.r19">[19]</xref> Similar to butterfly-shaped pattern dystrophy, ERG and EOG are normal or minimally abnormal in reticular dystrophy.</p>
        <p>Multifocal pattern dystrophy, resembling Stargardt or Fundus Flavimaculatus, demonstrates multiple irregular white-yellow flecks scattered throughout the macula, similar to the flecks seen in Stargardt disease. Lesions range from fleck deposits to confluent lesions of chorioretinal atrophy.<xref ref-type="bibr" rid="article-140255.r15">[15]</xref>&#x000a0;FA is key in distinguishing between Stargardts and this pattern dystrophy, as in multifocal pattern dystrophy, there is no dark choroid. Flecks are hyperfluorescent in both early and late stages.<xref ref-type="bibr" rid="article-140255.r15">[15]</xref>&#x000a0;</p>
        <p>A distinguishing aspect of multifocal dystrophy is that it affects the peripheral retina beyond the macula and can feature constriction of the peripheral visual field. Depending on the severity, this constriction may be debilitating. Additionally, in severe cases, patients may demonstrate full-field ERG abnormalities. Optical coherence tomography (OCT) will reveal the flecks as highly reflective areas of focal thickening.<xref ref-type="bibr" rid="article-140255.r20">[20]</xref>&#x000a0;Rare and advanced cases aside, multifocal dystrophy is distinct from Stargardts as it is not as visually devastating, features a distinct inheritance pattern (autosomal dominant), and there is the absence of a dark choroid on FA.<xref ref-type="bibr" rid="article-140255.r21">[21]</xref></p>
        <p>Adult-onset foveomacular vitelliform dystrophy (AFVD) is unique in that it is linked to mutations beyond the peripherin/RDS gene, such as mutations in the VMD2 gene.<xref ref-type="bibr" rid="article-140255.r22">[22]</xref> On exam, it features bilateral, symmetric, round, gray-white lesions in the macula.<xref ref-type="bibr" rid="article-140255.r23">[23]</xref>&#x000a0;</p>
        <p>Lesions are usually a third to a half of a disc diameter, with larger lesions appearing similar to Best vitelliform macular dystrophy.<xref ref-type="bibr" rid="article-140255.r24">[24]</xref>&#x000a0;On FA, the vitelliform lesion will show hypofluorescence with an area of hyperfluorescence surrounding it, while FAF reveals various patterns, including autofluorescent patterns that are patchy, linear, ring-like, and others.<xref ref-type="bibr" rid="article-140255.r25">[25]</xref>&#x000a0;</p>
        <p>One way to distinguish AVFD from Best is that both EOG and ERG in AVFD are normal.<xref ref-type="bibr" rid="article-140255.r26">[26]</xref>&#x000a0;Additionally,&#x000a0;vitelliform lesions typically first appear in the fourth decade or later and are smaller. OCT is another imaging modality that allows for the visualization of vitelliform lesions that are located subretinally.<xref ref-type="bibr" rid="article-140255.r27">[27]</xref>&#x000a0;</p>
        <p>Some patients with multiple drusen may develop vitelliform exudative macular detachments, and this fluid blocks background fluorescence early and stains late on FA. As such, AVFD may be mistaken for choroidal neovascularization. Patients with AVFD, unlike in choroidal neovascularization, will not respond with improvement in visual acuity after receiving anti-vascular endothelial growth factor or photodynamic therapy.</p>
        <p>Fundus pulverulentus features a granular appearance and punctiform mottling of the RPE within the macula.&#x000a0;Areas of pigment mottling appear as areas of hypofluorescence on FA.<xref ref-type="bibr" rid="article-140255.r28">[28]</xref>&#x000a0;Fundus pulverulentus can be mistaken for age-related macular degeneration due to the RPE mottling; however, OCT imaging and follow-up reveal different disease courses. While all pattern dystrophies share an association with pseudoxanthoma elasticum, fundus pulverulentus has the most common association.</p>
      </sec>
      <sec id="article-140255.s7" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>Visual prognosis is typically good in pattern dystrophies, with gradual visual changes and loss.<xref ref-type="bibr" rid="article-140255.r15">[15]</xref> There is no evidence-based treatment for the pigment deposition and lipofuscin accumulation seen in pattern dystrophies. However, vision loss can be more rapid in some patients due to secondary complications from choroidal neovascularization and macular holes necessitating treatment with anti-VEGF injections and surgical hole repair, respectively.<xref ref-type="bibr" rid="article-140255.r4">[4]</xref><xref ref-type="bibr" rid="article-140255.r6">[6]</xref>&#x000a0;</p>
        <p>In cases of slowly progressive vision loss or the less common rapid loss, low vision therapy remains the most prominent option to maximize function.</p>
      </sec>
      <sec id="article-140255.s8" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>Pattern dystrophies as a whole&#x000a0;may resemble AMD and must be worked up appropriately to ensure AMD is not present. A key differential for multifocal pattern dystrophy is Stargardt disease due to the similar appearance of the flecks in the macula and beyond. FA and genetic testing can help distinguish between the two. Best disease and choroidal neovascularization are differentials for AVFD and can be ruled out based on FA and EOG findings, respectively.</p>
      </sec>
      <sec id="article-140255.s9" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>Patients can be reassured that pattern dystrophies do not typically negatively impact their vision significantly, and progression is gradual. Due to the challenges of distinguishing pattern dystrophies from AMD, patients are often mistaken for having AMD and have received treatments targeting AMD such as vitamins, anti-VEGF injections, and PDT.</p>
        <p>Areas of atrophy may develop in older patients and affect central vision; however, patients can maintain reading vision in most cases. The majority of patients will not require intervention or treatment and can be followed over time.</p>
      </sec>
      <sec id="article-140255.s10" sec-type="Complications">
        <title>Complications</title>
        <p>Rarely may patients experience complications secondary to choroidal neovascularization, which is responsive to anti-VEGF therapy.<xref ref-type="bibr" rid="article-140255.r29">[29]</xref>&#x000a0;PDT should be avoided as it may negatively impact vision in patients with pattern dystrophy, especially those with AVFD.<xref ref-type="bibr" rid="article-140255.r30">[30]</xref>&#x000a0;Additionally, some patients with AVFD may develop macular holes. Unfortunately, vitrectomy for these patients is not effective.</p>
      </sec>
      <sec id="article-140255.s11" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Although most patients will maintain good vision and the disease is slowly progressive, there still needs to be follow-up and a full workup to ensure there is no concurrent AMD. Some may experience a more rapid course of vision loss, requiring low vision therapy. Rarely can patients experience complications such as choroidal neovascularization or macular holes, making it critically important to seek medical care if experiencing vision loss.</p>
      </sec>
      <sec id="article-140255.s12" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Retinal pattern dystrophies are a group of diseases characterized by various patterns of pigment deposition, primarily in the macula. Various forms of mutation in the RDS/peripherin gene form the genetic basis for these dystrophies. It is critical to distinguish pattern dystrophies from age-related macular degeneration by utilizing a complete workup including fluorescein angiography, fundus autofluorescence, electroretinogram, and electrooculogram.</p>
        <p>While most patients will experience a slowly progressive course with good visual acuity, a few will have a more rapid course causing a decline in central vision. There is no treatment for the pigment deposition; however, low vision aids are available for those few. Additionally, a minority of patients may experience complications such as macular holes or choroidal neovascularization, necessitating treatment with vitrectomy or anti-vascular endothelial growth factor injections.&#x000a0;</p>
        <p>It is important to refer patients suspected of retinal pattern dystrophy&#x000a0;to an ophthalmologist for further evaluation and testing so that the diagnosis can be confirmed, the patient appropriately followed, age-related macular degeneration&#x000a0;ruled out, and complications managed should they arise.</p>
        <p>Due to the complexity of diagnosis and potentially devastating consequences of complications such as choroidal neovascularization, the healthcare professional's consultation with ophthalmology should be done promptly in cases of suspected&#x000a0;pattern dystrophy.</p>
      </sec>
      <sec id="article-140255.s13">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=140255&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=140255">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/eye-health/retinal-pattern-dystrophy/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=140255">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/140255/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=140255">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-140255.s14">
        <fig id="article-140255.image.f1" position="float" orientation="portrait">
          <caption>
            <p>FAF with both increased and decreased autofluorescence corresponding to lipofuscin changes in butterfly pattern dystrophy. Contributed by David Sierpina, MD</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="FAFButterfly" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-140255.s15">
        <fig id="article-140255.image.f2" position="float" orientation="portrait">
          <caption>
            <p>FA images of multifocal pattern dystrophy Contributed by David Sierpina, MD</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="multifocal__pattern__dystrophy__FA" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-140255.s16">
        <fig id="article-140255.image.f3" position="float" orientation="portrait">
          <caption>
            <p>FAF of adult onset foveomacular vitelliform dystrophy. Contributed by David Sierpina, MD</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="FAFAVFD" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-140255.s17">
        <title>References</title>
        <ref id="article-140255.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Deutman</surname>
                <given-names>AF</given-names>
              </name>
              <name>
                <surname>van Blommestein</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Henkes</surname>
                <given-names>HE</given-names>
              </name>
              <name>
                <surname>Waardenburg</surname>
                <given-names>PJ</given-names>
              </name>
              <name>
                <surname>Solleveld-van Driest</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Butterfly-shaped pigment dystrophy of the fovea.</article-title>
            <source>Arch Ophthalmol</source>
            <year>1970</year>
            <month>May</month>
            <volume>83</volume>
            <issue>5</issue>
            <fpage>558</fpage>
            <page-range>558-69</page-range>
            <pub-id pub-id-type="pmid">5442145</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140255.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Weleber</surname>
                <given-names>RG</given-names>
              </name>
              <name>
                <surname>Carr</surname>
                <given-names>RE</given-names>
              </name>
              <name>
                <surname>Murphey</surname>
                <given-names>WH</given-names>
              </name>
              <name>
                <surname>Sheffield</surname>
                <given-names>VC</given-names>
              </name>
              <name>
                <surname>Stone</surname>
                <given-names>EM</given-names>
              </name>
            </person-group>
            <article-title>Phenotypic variation including retinitis pigmentosa, pattern dystrophy, and fundus flavimaculatus in a single family with a deletion of codon 153 or 154 of the peripherin/RDS gene.</article-title>
            <source>Arch Ophthalmol</source>
            <year>1993</year>
            <month>Nov</month>
            <volume>111</volume>
            <issue>11</issue>
            <fpage>1531</fpage>
            <page-range>1531-42</page-range>
            <pub-id pub-id-type="pmid">8240110</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140255.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kim</surname>
                <given-names>RY</given-names>
              </name>
              <name>
                <surname>Dollfus</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Keen</surname>
                <given-names>TJ</given-names>
              </name>
              <name>
                <surname>Fitzke</surname>
                <given-names>FW</given-names>
              </name>
              <name>
                <surname>Arden</surname>
                <given-names>GB</given-names>
              </name>
              <name>
                <surname>Bhattacharya</surname>
                <given-names>SS</given-names>
              </name>
              <name>
                <surname>Bird</surname>
                <given-names>AC</given-names>
              </name>
            </person-group>
            <article-title>Autosomal dominant pattern dystrophy of the retina associated with a 4-base pair insertion at codon 140 in the peripherin/RDS gene.</article-title>
            <source>Arch Ophthalmol</source>
            <year>1995</year>
            <month>Apr</month>
            <volume>113</volume>
            <issue>4</issue>
            <fpage>451</fpage>
            <page-range>451-5</page-range>
            <pub-id pub-id-type="pmid">7710395</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140255.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yang</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Jiang</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Karan</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Moshfeghi</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>O'Connor</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Yu</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Lewis</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Zack</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Jacobson</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>A novel RDS/peripherin gene mutation associated with diverse macular phenotypes.</article-title>
            <source>Ophthalmic Genet</source>
            <year>2004</year>
            <month>Jun</month>
            <volume>25</volume>
            <issue>2</issue>
            <fpage>133</fpage>
            <page-range>133-45</page-range>
            <pub-id pub-id-type="pmid">15370544</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140255.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fossarello</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Bertini</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Galantuomo</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Cao</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Serra</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Pirastu</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Deletion in the peripherin/RDS gene in two unrelated Sardinian families with autosomal dominant butterfly-shaped macular dystrophy.</article-title>
            <source>Arch Ophthalmol</source>
            <year>1996</year>
            <month>Apr</month>
            <volume>114</volume>
            <issue>4</issue>
            <fpage>448</fpage>
            <page-range>448-56</page-range>
            <pub-id pub-id-type="pmid">8602784</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140255.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Francis</surname>
                <given-names>PJ</given-names>
              </name>
              <name>
                <surname>Schultz</surname>
                <given-names>DW</given-names>
              </name>
              <name>
                <surname>Gregory</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Schain</surname>
                <given-names>MB</given-names>
              </name>
              <name>
                <surname>Barra</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Majewski</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Ott</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Acott</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Weleber</surname>
                <given-names>RG</given-names>
              </name>
              <name>
                <surname>Klein</surname>
                <given-names>ML</given-names>
              </name>
            </person-group>
            <article-title>Genetic and phenotypic heterogeneity in pattern dystrophy.</article-title>
            <source>Br J Ophthalmol</source>
            <year>2005</year>
            <month>Sep</month>
            <volume>89</volume>
            <issue>9</issue>
            <fpage>1115</fpage>
            <page-range>1115-9</page-range>
            <pub-id pub-id-type="pmid">16113362</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140255.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zhang</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Garibaldi</surname>
                <given-names>DC</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Green</surname>
                <given-names>WR</given-names>
              </name>
              <name>
                <surname>Zack</surname>
                <given-names>DJ</given-names>
              </name>
            </person-group>
            <article-title>Butterfly-shaped pattern dystrophy: a genetic, clinical, and histopathological report.</article-title>
            <source>Arch Ophthalmol</source>
            <year>2002</year>
            <month>Apr</month>
            <volume>120</volume>
            <issue>4</issue>
            <fpage>485</fpage>
            <page-range>485-90</page-range>
            <pub-id pub-id-type="pmid">11934323</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140255.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nichols</surname>
                <given-names>BE</given-names>
              </name>
              <name>
                <surname>Sheffield</surname>
                <given-names>VC</given-names>
              </name>
              <name>
                <surname>Vandenburgh</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Drack</surname>
                <given-names>AV</given-names>
              </name>
              <name>
                <surname>Kimura</surname>
                <given-names>AE</given-names>
              </name>
              <name>
                <surname>Stone</surname>
                <given-names>EM</given-names>
              </name>
            </person-group>
            <article-title>Butterfly-shaped pigment dystrophy of the fovea caused by a point mutation in codon 167 of the RDS gene.</article-title>
            <source>Nat Genet</source>
            <year>1993</year>
            <month>Mar</month>
            <volume>3</volume>
            <issue>3</issue>
            <fpage>202</fpage>
            <page-range>202-7</page-range>
            <pub-id pub-id-type="pmid">8485574</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140255.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Downes</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Fitzke</surname>
                <given-names>FW</given-names>
              </name>
              <name>
                <surname>Holder</surname>
                <given-names>GE</given-names>
              </name>
              <name>
                <surname>Payne</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Bessant</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Bhattacharya</surname>
                <given-names>SS</given-names>
              </name>
              <name>
                <surname>Bird</surname>
                <given-names>AC</given-names>
              </name>
            </person-group>
            <article-title>Clinical features of codon 172 RDS macular dystrophy: similar phenotype in 12 families.</article-title>
            <source>Arch Ophthalmol</source>
            <year>1999</year>
            <month>Oct</month>
            <volume>117</volume>
            <issue>10</issue>
            <fpage>1373</fpage>
            <page-range>1373-83</page-range>
            <pub-id pub-id-type="pmid">10532447</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140255.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kohl</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Christ-Adler</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Apfelstedt-Sylla</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Kellner</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Eckstein</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Zrenner</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Wissinger</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>RDS/peripherin gene mutations are frequent causes of central retinal dystrophies.</article-title>
            <source>J Med Genet</source>
            <year>1997</year>
            <month>Aug</month>
            <volume>34</volume>
            <issue>8</issue>
            <fpage>620</fpage>
            <page-range>620-6</page-range>
            <pub-id pub-id-type="pmid">9279751</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140255.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Connell</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Bascom</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Molday</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Reid</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>McInnes</surname>
                <given-names>RR</given-names>
              </name>
              <name>
                <surname>Molday</surname>
                <given-names>RS</given-names>
              </name>
            </person-group>
            <article-title>Photoreceptor peripherin is the normal product of the gene responsible for retinal degeneration in the rds mouse.</article-title>
            <source>Proc Natl Acad Sci U S A</source>
            <year>1991</year>
            <month>Feb</month>
            <day>01</day>
            <volume>88</volume>
            <issue>3</issue>
            <fpage>723</fpage>
            <page-range>723-6</page-range>
            <pub-id pub-id-type="pmid">1992463</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140255.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Travis</surname>
                <given-names>GH</given-names>
              </name>
              <name>
                <surname>Sutcliffe</surname>
                <given-names>JG</given-names>
              </name>
              <name>
                <surname>Bok</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>The retinal degeneration slow (rds) gene product is a photoreceptor disc membrane-associated glycoprotein.</article-title>
            <source>Neuron</source>
            <year>1991</year>
            <month>Jan</month>
            <volume>6</volume>
            <issue>1</issue>
            <fpage>61</fpage>
            <page-range>61-70</page-range>
            <pub-id pub-id-type="pmid">1986774</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140255.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Puech</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Kostrubiec</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Hache</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Fran&#x000e7;ois</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>[Epidemiology and prevalence of hereditary retinal dystrophies in the Northern France].</article-title>
            <source>J Fr Ophtalmol</source>
            <year>1991</year>
            <volume>14</volume>
            <issue>3</issue>
            <fpage>153</fpage>
            <page-range>153-64</page-range>
            <pub-id pub-id-type="pmid">1918822</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140255.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dalvin</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>Pulido</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Marmorstein</surname>
                <given-names>AD</given-names>
              </name>
            </person-group>
            <article-title>Vitelliform dystrophies: Prevalence in Olmsted County, Minnesota, United States.</article-title>
            <source>Ophthalmic Genet</source>
            <year>2017</year>
            <season>Mar-Apr</season>
            <volume>38</volume>
            <issue>2</issue>
            <fpage>143</fpage>
            <page-range>143-147</page-range>
            <pub-id pub-id-type="pmid">27120116</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140255.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Boon</surname>
                <given-names>CJ</given-names>
              </name>
              <name>
                <surname>van Schooneveld</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>den Hollander</surname>
                <given-names>AI</given-names>
              </name>
              <name>
                <surname>van Lith-Verhoeven</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Zonneveld-Vrieling</surname>
                <given-names>MN</given-names>
              </name>
              <name>
                <surname>Theelen</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Cremers</surname>
                <given-names>FP</given-names>
              </name>
              <name>
                <surname>Hoyng</surname>
                <given-names>CB</given-names>
              </name>
              <name>
                <surname>Klevering</surname>
                <given-names>BJ</given-names>
              </name>
            </person-group>
            <article-title>Mutations in the peripherin/RDS gene are an important cause of multifocal pattern dystrophy simulating STGD1/fundus flavimaculatus.</article-title>
            <source>Br J Ophthalmol</source>
            <year>2007</year>
            <month>Nov</month>
            <volume>91</volume>
            <issue>11</issue>
            <fpage>1504</fpage>
            <page-range>1504-11</page-range>
            <pub-id pub-id-type="pmid">17504850</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140255.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Agarwal</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Patel</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Adkins</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Gass</surname>
                <given-names>JD</given-names>
              </name>
            </person-group>
            <article-title>Spectrum of pattern dystrophy in pseudoxanthoma elasticum.</article-title>
            <source>Arch Ophthalmol</source>
            <year>2005</year>
            <month>Jul</month>
            <volume>123</volume>
            <issue>7</issue>
            <fpage>923</fpage>
            <page-range>923-8</page-range>
            <pub-id pub-id-type="pmid">16009832</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140255.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Massin</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Virally-Monod</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Vialettes</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Paques</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Gin</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Porokhov</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Caillat-Zucman</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Froguel</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Paquis-Fluckinger</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Gaudric</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Guillausseau</surname>
                <given-names>PJ</given-names>
              </name>
            </person-group>
            <article-title>Prevalence of macular pattern dystrophy in maternally inherited diabetes and deafness. GEDIAM Group.</article-title>
            <source>Ophthalmology</source>
            <year>1999</year>
            <month>Sep</month>
            <volume>106</volume>
            <issue>9</issue>
            <fpage>1821</fpage>
            <page-range>1821-7</page-range>
            <pub-id pub-id-type="pmid">10485557</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140255.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chen</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Chang</surname>
                <given-names>CC</given-names>
              </name>
              <name>
                <surname>Tsai</surname>
                <given-names>TH</given-names>
              </name>
              <name>
                <surname>Fan</surname>
                <given-names>IM</given-names>
              </name>
              <name>
                <surname>Hou</surname>
                <given-names>PK</given-names>
              </name>
            </person-group>
            <article-title>Reticular dystrophy of the retinal pigment epithelium.</article-title>
            <source>J Formos Med Assoc</source>
            <year>2007</year>
            <month>Jun</month>
            <volume>106</volume>
            <issue>6</issue>
            <fpage>490</fpage>
            <page-range>490-4</page-range>
            <pub-id pub-id-type="pmid">17588843</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140255.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Marano</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Deutman</surname>
                <given-names>AF</given-names>
              </name>
              <name>
                <surname>Pinckers</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Aandekerk</surname>
                <given-names>AL</given-names>
              </name>
              <name>
                <surname>Rijneveld</surname>
                <given-names>WJ</given-names>
              </name>
            </person-group>
            <article-title>Reticular dystrophy of the retinal pigment epithelium and choroidal neovascularization. A fluorescein and ICGV study.</article-title>
            <source>Acta Ophthalmol Scand</source>
            <year>1997</year>
            <month>Feb</month>
            <volume>75</volume>
            <issue>1</issue>
            <fpage>22</fpage>
            <page-range>22-7</page-range>
            <pub-id pub-id-type="pmid">9088395</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140255.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ghazi</surname>
                <given-names>NG</given-names>
              </name>
              <name>
                <surname>Dibernardo</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Ying</surname>
                <given-names>HS</given-names>
              </name>
              <name>
                <surname>Mori</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Gehlbach</surname>
                <given-names>PL</given-names>
              </name>
            </person-group>
            <article-title>Optical coherence tomography of enucleated human eye specimens with histological correlation: origin of the outer "red line".</article-title>
            <source>Am J Ophthalmol</source>
            <year>2006</year>
            <month>Apr</month>
            <volume>141</volume>
            <issue>4</issue>
            <fpage>719</fpage>
            <page-range>719-26</page-range>
            <pub-id pub-id-type="pmid">16564808</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140255.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tuppurainen</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>M&#x000e4;ntyj&#x000e4;rvi</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>The importance of fluorescein angiography in diagnosing pattern dystrophies of the retinal pigment epithelium.</article-title>
            <source>Doc Ophthalmol</source>
            <year>1994</year>
            <volume>87</volume>
            <issue>3</issue>
            <fpage>233</fpage>
            <page-range>233-43</page-range>
            <pub-id pub-id-type="pmid">7835193</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140255.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Felbor</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Schilling</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Weber</surname>
                <given-names>BH</given-names>
              </name>
            </person-group>
            <article-title>Adult vitelliform macular dystrophy is frequently associated with mutations in the peripherin/RDS gene.</article-title>
            <source>Hum Mutat</source>
            <year>1997</year>
            <volume>10</volume>
            <issue>4</issue>
            <fpage>301</fpage>
            <page-range>301-9</page-range>
            <pub-id pub-id-type="pmid">9338584</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140255.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Renner</surname>
                <given-names>AB</given-names>
              </name>
              <name>
                <surname>Tillack</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Kraus</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Kohl</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Wissinger</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Mohr</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Weber</surname>
                <given-names>BH</given-names>
              </name>
              <name>
                <surname>Kellner</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Foerster</surname>
                <given-names>MH</given-names>
              </name>
            </person-group>
            <article-title>Morphology and functional characteristics in adult vitelliform macular dystrophy.</article-title>
            <source>Retina</source>
            <year>2004</year>
            <month>Dec</month>
            <volume>24</volume>
            <issue>6</issue>
            <fpage>929</fpage>
            <page-range>929-39</page-range>
            <pub-id pub-id-type="pmid">15579992</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140255.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Boon</surname>
                <given-names>CJ</given-names>
              </name>
              <name>
                <surname>Klevering</surname>
                <given-names>BJ</given-names>
              </name>
              <name>
                <surname>den Hollander</surname>
                <given-names>AI</given-names>
              </name>
              <name>
                <surname>Zonneveld</surname>
                <given-names>MN</given-names>
              </name>
              <name>
                <surname>Theelen</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Cremers</surname>
                <given-names>FP</given-names>
              </name>
              <name>
                <surname>Hoyng</surname>
                <given-names>CB</given-names>
              </name>
            </person-group>
            <article-title>Clinical and genetic heterogeneity in multifocal vitelliform dystrophy.</article-title>
            <source>Arch Ophthalmol</source>
            <year>2007</year>
            <month>Aug</month>
            <volume>125</volume>
            <issue>8</issue>
            <fpage>1100</fpage>
            <page-range>1100-6</page-range>
            <pub-id pub-id-type="pmid">17698758</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140255.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Parodi</surname>
                <given-names>MB</given-names>
              </name>
              <name>
                <surname>Iacono</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Pedio</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Pece</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Isola</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Fachin</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Pinto</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ravalico</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Autofluorescence in adult-onset foveomacular vitelliform dystrophy.</article-title>
            <source>Retina</source>
            <year>2008</year>
            <month>Jun</month>
            <volume>28</volume>
            <issue>6</issue>
            <fpage>801</fpage>
            <page-range>801-7</page-range>
            <pub-id pub-id-type="pmid">18536595</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140255.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Theischen</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Schilling</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Steinhorst</surname>
                <given-names>UH</given-names>
              </name>
            </person-group>
            <article-title>[EOG in adult vitelliform macular degeneration, butterfly-shaped pattern dystrophy and Best disease].</article-title>
            <source>Ophthalmologe</source>
            <year>1997</year>
            <month>Mar</month>
            <volume>94</volume>
            <issue>3</issue>
            <fpage>230</fpage>
            <page-range>230-3</page-range>
            <pub-id pub-id-type="pmid">9181841</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140255.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pierro</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Tremolada</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Introini</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Calori</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Brancato</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Optical coherence tomography findings in adult-onset foveomacular vitelliform dystrophy.</article-title>
            <source>Am J Ophthalmol</source>
            <year>2002</year>
            <month>Nov</month>
            <volume>134</volume>
            <issue>5</issue>
            <fpage>675</fpage>
            <page-range>675-80</page-range>
            <pub-id pub-id-type="pmid">12429242</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140255.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Battaglia Parodi</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Choroidal neovascularization in fundus pulverulentus.</article-title>
            <source>Acta Ophthalmol Scand</source>
            <year>2002</year>
            <month>Oct</month>
            <volume>80</volume>
            <issue>5</issue>
            <fpage>559</fpage>
            <page-range>559-60</page-range>
            <pub-id pub-id-type="pmid">12390174</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140255.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Empeslidis</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Vardarinos</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Deane</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Banerjee</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Intravitreal ranibizumab in the treatment of butterfly-shaped pattern dystrophy associated with choroidal neovascularization: a case report.</article-title>
            <source>Case Rep Ophthalmol</source>
            <year>2012</year>
            <month>Jan</month>
            <volume>3</volume>
            <issue>1</issue>
            <fpage>77</fpage>
            <page-range>77-82</page-range>
            <pub-id pub-id-type="pmid">22529806</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140255.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ergun</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Costa</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Slakter</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Yannuzzi</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>Stur</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Photodynamic therapy and vitelliform lesions.</article-title>
            <source>Retina</source>
            <year>2004</year>
            <month>Jun</month>
            <volume>24</volume>
            <issue>3</issue>
            <fpage>399</fpage>
            <page-range>399-406</page-range>
            <pub-id pub-id-type="pmid">15187662</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
